EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
4.280
+0.030 (0.71%)
At close: Sep 11, 2026, 4:00 PM EDT
4.230
-0.050 (-1.17%)
After-hours: Sep 11, 2026, 7:30 PM EDT
EyePoint Market Cap
EyePoint has a market cap or net worth of $364.68 million as of September 11, 2026. Its market cap has decreased by -60.96% in one year.
Market Cap
364.68M
Enterprise Value
206.57M
1-Year Change
-60.96%
Ranking
Category
Stock Price
$4.28
ChartMarket Cap Chart
Since January 27, 2005, EyePoint's market cap has decreased from $388.60M to $364.68M, a decrease of -6.16%. That is a compound annual growth rate of -0.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 364.70M | -75.89% |
| Dec 31, 2025 | 1.51B | 197.44% |
| Dec 31, 2024 | 508.50M | -37.68% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 384.69M |
| Enanta Pharmaceuticals | 370.48M |
| Compass Therapeutics | 367.38M |
| Palisade Bio | 363.35M |
| Rocket Pharmaceuticals | 357.87M |
| Orchestra BioMed Holdings | 357.63M |
| Century Therapeutics | 349.48M |
| Sionna Therapeutics | 349.04M |